ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results.

Joseph Pidala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.